Physician profile
Vinodh Doss
NPI 1336348085
$5,410.39
in general payments reported to CMS, 2019-2025
15 companies · $541 in 2025
The $541 reported for 2025 was more than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,296 · 2020: $584 · 2021: $199 · 2022: $1,088 · 2023: $284 · 2024: $419 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,243.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $2,080.65 | 2019-2023 | Azur Cx Detachable, Web Aneurysm Embolization System, Eric Retrieval Device |
| Balt USA, LLC | $800.13 | 2019-2022 | |
| Imperative Care, INC | $723.98 | 2022-2025 | Zoom 88-T Large Distal Platform |
| Medtronic, INC. | $622.24 | 2021-2025 | Mo.Ma Ultra, Solitaire X, Pipeline |
| Penumbra, INC. | $330.14 | 2019-2024 | Penumbra System, Benchmark |
| Asahi Intecc USA, INC. | $304.15 | 2020-2024 | Peripheral Vascular, Asahi Ptca Guide Wire |
| Medtronic USA, INC. | $155.96 | 2019 | |
| Stryker Corporation | $109.02 | 2020-2025 | Surpass Evolve |
| Portola Pharmaceuticals, LLC | $73.47 | 2019 | |
| Route 92 Medical, INC. | $62.73 | 2023-2024 | 8f Base Camp Sheath System |
| Qapel Medical INC | $44.70 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $35.00 | 2023 | Andexxa |
| Ucb, INC. | $24.86 | 2023 | Briviact |
| Siemens Medical Solutions USA, INC. | $22.84 | 2019 | |
| Sk Life Science, INC. | $20.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinodh Doss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.